Skip to main content
. 2024 Oct 18;6(5):dlae160. doi: 10.1093/jacamr/dlae160

Figure 1.

Figure 1.

Percentage of resistant strains in HA-MRSA and CA-MRSA. CLI, clindamycin; ERY, erythromycin; GEN, gentamicin; LVX, levofloxacin; LZD, linezolid; RIF, rifampicin; SXT, trimethoprim/sulfamethoxazole.